By Dr John Walter Frew

Conference Papers

Orenstein LAV; Shi VY; Lev-Tov H; Prens E; Ingram JR; Frew JW; Fujita H; Rolleri R; Lambert J; Crater C; Bechara FG; Davis L; Szepietowski JC, 2025, '2-year Impact of Bimekizumab on HSSQ Skin Pain in moderate to severe HS: Data from BE HEARD EXT', in JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, WILEY, pp. 133 - 133

Orenstein LA; Shi VY; Lev-Tov H; Prens E; Ingram JR; Frew JW; Fujita H; Rolleri R; Lambert J; Crater C; Bechara FG; Davis L; Szepietowski JC, 2025, '2-year impact of bimekizumab on HSSQ skin pain in moderate to severe HS: data from BE HEARD EXT', in JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, WILEY

Tzellos T; Sayed CJ; Gottlieb AB; Becherel P-A; Kirby B; Asai J; Frew JW; Pansar I; Tilt N; Rolleri R; Porter ML, 2025, 'Bimekizumab impact on draining tunnel reduction over 2 years in moderate to severe hidradenitis suppurativa: Results from BE HEARD EXT', in JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, MOSBY-ELSEVIER, pp. AB137 - AB137

Sayed CJ; Kirby B; Frew JW; Porter ML; Ingram JR; Prens E; Charrow AP; Gooderham MJ; Savage L; Reich K; Bechara FG, 2025, 'IHS4-100 responses and other IHS4 outcomes with the IL-17A-and IL-17F-inhibiting Nanobody sonelokimab in patients with moderate-to-severe hidradenitis suppurativa (HS): Week 24 results from the Phase 2 MIRA trial', in JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, MOSBY-ELSEVIER, pp. AB221 - AB221

Porter ML; Kirby B; Krueger JG; Bechara FG; Frew JW; Sayed CJ; Pinter A; Szepietowski JC; Bertolini M; Reich K; Kimball AB, 2025, 'Resolution of deep dermal inflammatory lesions with the Nano-body sonelokimab in moderate-to-severe hidradenitis suppurativa (HS): preclinical results and outcomes from the Phase 2 MIRA trial', in JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, MOSBY-ELSEVIER

Frew J; Flora A; Pham J; Woods J; Radzieta M; Dickson H; Malone M, 2025, 'The Clinical and Molecular Response of Pyoderma Gangrenosum to Interleukin 23 Blockade: Result from a proof-of-concept open-label clinical trial', in JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, MOSBY-ELSEVIER, pp. AB313 - AB313

van der Zee HH; Kirby B; Bechara FG; Jemec GBE; Frew JW; Rolleri R; Joshi P; Pansar I; Tilt N; Sayed CJ, 2024, 'Bimekizumab impact on lesion count by anatomical region in moderate to severe hidradenitis suppurativa: Results to week 48 from BE HEARD I & II', in EXPERIMENTAL DERMATOLOGY, WILEY, FRANCE, Lyon, presented at 13th European Hidradenitis Suppurativa Conference (EHSF), FRANCE, Lyon, 07 February 2024 - 09 February 2024

Zouboulis CC; Kirby JS; Tzellos T; Khattri S; Alavi A; Podda M; del Marmol V; Spelman L; Rolleri R; Joshi P; Davis L; Pansar I; Frew JW, 2024, 'IHS4 outcomes with bimekizumab in patients with moderate to severe hidradenitis suppurativa: Pooled results from the BE HEARD I & II phase 3 trials', in EXPERIMENTAL DERMATOLOGY, WILEY, FRANCE, Lyon, presented at 13th European Hidradenitis Suppurativa Conference (EHSF), FRANCE, Lyon, 07 February 2024 - 09 February 2024

Kirby B; Frew JW; Porter MJ; Bechara FG; Ingram JR; Prens EP; Charrow AP; Sayed CJ; Brennan N; Godwood A; Attar N; Cullen E; Reich K, 2024, 'The IL-17A-and IL-17F-inhibiting Nanobody® sonelokimab in patients with moderate-to-severe hidradenitis suppurativa (HS): Week 12 International Hidradenitis Suppurativa Severity Score System (IHS4) results from the phase 2 MIRA trial', in EXPERIMENTAL DERMATOLOGY, WILEY, FRANCE, Lyon, presented at 13th European Hidradenitis Suppurativa Conference (EHSF), FRANCE, Lyon, 07 February 2024 - 09 February 2024

Zarroug M; Shaheen A; Mohammed A; Elgendy M; Burns A; AlHilali M; Vanderputten M; Azzabi A; Chandler R; Frew J; Hayhurst H; Jackson M; Pedley I; Pearson R; Jiang X, 2023, 'Brain directed therapy followed by systemic treatment in metastatic renal cell carcinoma', in RADIOTHERAPY AND ONCOLOGY, ELSEVIER IRELAND LTD, AUSTRIA, Vienna, pp. S894 - S894, presented at Annual Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO), AUSTRIA, Vienna, 12 May 2023 - 16 May 2023

Flora A; Jepsen R; Kozera E; Woods J; Cains G; Radzieta M; Malone M; Frew JW, 2023, 'Human dermal fibroblasts and mast cell populations are altered in hidradenitis suppurativa, with epithelial-mesenchymal-transition signals ameliorated by spleen tyrosine kinase antagonism.', in JOURNAL OF INVESTIGATIVE DERMATOLOGY, ELSEVIER SCIENCE INC, JAPAN, Tokyo, pp. S227 - S227, presented at 1st International Societies for Investigative Dermatology Meeting, JAPAN, Tokyo, 12 May 2023 - 13 May 2023

Paton E; Fogarty G; Murrell D; Frew J, 2023, 'A proposed phase I trial evaluating Volumetric Modulated Arc Therapy ( VMAT) radiotherapy (RT) in patients with recalcitrant Hidradenitis Suppurativa (HS)', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY, pp. 51 - 52

Kozera E; Flora A; Stewart T; Gill K; De la Vega MA; Frew J, 2023, 'Dupilumab-associated head and neck dermatitis resolves temporarily with itraconazole therapy and rapidly with transition to upadacitinib, with malassezia-specific immunoglobulin e levels mirroring cli', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY, pp. 12 - 12

Flora A; Frew J, 2023, 'Hidradenitis Suppurativa: Clinical, hormonal and molecular markers associated with clinical response to IL-23 antagonism -A Prospective Cohort Study', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY, pp. 15 - 15

Pham J; Frew J, 2023, 'Resident cutaneous memory T-cells: A review of their role in modulating chronic inflammatory dermatoses and potential as therapeutic targets', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY, pp. 80 - 81

Jepsen R; Flora A; Kozera E; Frew JW, 2023, 'SYK antagonism in hidradenitis suppurativa demonstrates clinical efficacy with grearter response in B-cell predominant disease: Results of a open-label, proof-of-concept phase 2 clinical trial', in JOURNAL OF INVESTIGATIVE DERMATOLOGY, ELSEVIER SCIENCE INC, pp. B15 - B15

Flora A; Frew J; Woods J, 2023, 'Tick bite induced meat allergy: A presentation of two cases and review of the literature', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY, pp. 57 - 58

Pham JP; Glasenhardt K; Garg A; Frew JW, 2022, 'Interpretation of comorbidity risk in hidradenitis suppurativa: comparing odds ratio and ‘number needed to be exposed’', in Journal of the European Academy of Dermatology and Venereology, pp. e1004 - e1006, http://dx.doi.org/10.1111/jdv.18403

Kuhnl A; Mikhaeel G; Kirkwood AA; Menne TF; Frew J; Tholouli E; Patel A; Besley CM; Beasley MJ; Latif AL; O'Rourke N; Nicholson E; Alexander E; Chaganti S; Stevens AM; Marzolini MAV; Johnson RJ; Sanderson R; Sivabalasingham S; Roddie C, 2021, 'Radiotherapy Bridging in Patients With R/R High-Grade Lymphoma Receiving CD19 CAR-T in the UK', in INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, ELSEVIER SCIENCE INC, pp. S130 - S130

Tree AC; Hall E; Ostler P; van der Voet H; Loblaw A; Chu W; Ford D; Tolan S; Jain S; Martin A; Staffurth J; Camilleri P; Kancherla K; Frew J; Brand DH; Chan A; Dayes IS; Brown S; Pugh J; Burnett S; Dufton A; Griffin C; Mahmud M; Naismith O; van As N, 2021, 'Comparison of side effects at 2 years in the randomised PACE-B trial (SBRT vs standard radiotherapy)', in RADIOTHERAPY AND ONCOLOGY, ELSEVIER IRELAND LTD, pp. S197 - S197, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000709667200220&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Jackson M; Hannaway N; Burns A; Pearson R; Chandler R; Frew J; Azzabi A; Jiang X, 2021, 'High dose palliative radiotherapy in bladder cancer - A single centre experience from the UK', in RADIOTHERAPY AND ONCOLOGY, ELSEVIER IRELAND LTD, pp. S1152 - S1153, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000709667203302&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Navrazhina K; Renert-Yuval Y; Frew J; Grand D; Garcet S; Krueger JG, 2021, 'Blood analysis uncovers novel inflammatory, oncologic and cardiovascular biomarkers in psoriasis and Hidradenitis Suppurativa', in JOURNAL OF INVESTIGATIVE DERMATOLOGY, ELSEVIER SCIENCE INC, pp. S122 - S122, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000641872800701&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Williams S; Navrazhina K; Frew J; Garcet S; Krueger JG, 2021, 'Vascularization in the deep dermis of hidradenitis suppurativa lesions', in JOURNAL OF INVESTIGATIVE DERMATOLOGY, ELSEVIER SCIENCE INC, pp. S121 - S121, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000641872800698&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

McCallum H; Wyatt JJ; Frew J; Walker C; Richmond N; Wilkinson M; Driver S; Pilling K; Rachel L B; West S; Pearson RA, 2020, 'Real-life experiences of an MR-Only prostate radiotherapy pathway with MR-CBCT soft-tissue matching', in RADIOTHERAPY AND ONCOLOGY, ELSEVIER IRELAND LTD, pp. S1001 - S1002, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000648572703314&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Frew JW; Navrazhina K; Garcet S; Krueger J, 2020, 'Targeted IL-17RA antagonism ameliorates histological and transcriptomic features of hidradenitis suppurativa: A proof of concept study', in JOURNAL OF INVESTIGATIVE DERMATOLOGY, ELSEVIER SCIENCE INC, ELECTR NETWORK, pp. S115 - S115, presented at Virtual Conference of the Society-for-Investigative-Dermatology (SID ), ELECTR NETWORK, 13 May 2020 - 16 May 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000554564400719&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Wyatt J; Pearson RA; Frew J; Walker C; Richmond N; Wilkinson M; Wilkes K; Driver S; West S; Pilling K; Brooks RL; Ainslie D; Wilkins E; McCallum HM, 2020, 'Evaluation of first 20 patients treated with MR-Only prostate radiotherapy with MR-CBCT matching', in RADIOTHERAPY AND ONCOLOGY, ELSEVIER IRELAND LTD, pp. S265 - S265

Pearson R; Samuel R; McCallum H; Frew J; Howell E; Maxwell R, 2019, '18F-Choline-PET-CT to guide simultaneous integrated boost in prostate cancer', in RADIOTHERAPY AND ONCOLOGY, ELSEVIER IRELAND LTD, ITALY, Milan, pp. S1115 - S1115, presented at 38th Annual Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO), ITALY, Milan, 26 April 2019 - 30 April 2019, http://dx.doi.org/10.1016/S0167-8140(19)32451-X

Wyatt J; Frew J; Henry A; Murray L; Pearson R; McNeil A; Johnstone E; Speight R; McCallum H, 2019, 'Investigating a new MR sequence combined with radiologist training for prostate delineation', in RADIOTHERAPY AND ONCOLOGY, ELSEVIER IRELAND LTD, ITALY, Milan, pp. S1124 - S1125, presented at 38th Annual Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO), ITALY, Milan, 26 April 2019 - 30 April 2019, http://dx.doi.org/10.1016/S0167-8140(19)32467-3

Pearson R; Jiang X; Atkinson S; Cumming S; Burns A; Frew J; McMenemin R; Pedley I; Azzabi A, 2019, 'Radium-223 treatment in Metastatic Prostate Cancer: Prognostic Factors: Real-world Outcome', in RADIOTHERAPY AND ONCOLOGY, ELSEVIER IRELAND LTD, ITALY, Milan, pp. S855 - S855, presented at 38th Annual Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO), ITALY, Milan, 26 April 2019 - 30 April 2019, http://dx.doi.org/10.1016/S0167-8140(19)32004-3

Jiang XY; Atkinson S; Cumming S; Burns A; Pearson R; Frew J; McMenemin R; Azzabi A; Leaning D; Pedley I, 2019, 'Radium-223 therapy in symptomatic metastatic castrate resistant prostate cancer (mCRPC) - sequential use post-abiraterone/prednisolone', in CLINICAL ONCOLOGY, ELSEVIER SCIENCE LONDON, pp. E10 - E11, http://dx.doi.org/10.1016/j.clon.2019.09.012

Watson N; Fatah S; Bacon C; Frew J; Weatherhead S, 2018, 'A rare cause of blistering: aggressive bullous cutaneous T-cell lymphoma', in BRITISH JOURNAL OF DERMATOLOGY, WILEY, SCOTLAND, Edinburgh, pp. 24 - 24, presented at 98th Annual Meeting of the British-Association-of-Dermatologists (BAD), SCOTLAND, Edinburgh, 03 July 2018 - 05 July 2018

Tatian A; Slape D; Frew J, 2018, 'Pachyonychia congenita tarda: A systematic review of case reports', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY, pp. 116 - 117, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000431000100319&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Frew JW; Choy B; Woods JA; Satchell AC, 2018, 'Secukinumab: An emerging successful therapy for pityriasis rubra pilaris: An Australian case series', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY, pp. 24 - 24, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000431000100068&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Wyatt J; Frew J; Henry A; Murray L; Pearson R; Johnstone E; Speight R; McCallum H, 2018, 'Investigating a new MR sequence for prostate delineation for radiotherapy', in RADIOTHERAPY AND ONCOLOGY, ELSEVIER IRELAND LTD, SPAIN, Barcelona, pp. S1172 - S1172, presented at 37th Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO), SPAIN, Barcelona, 20 April 2018 - 24 April 2018, http://dx.doi.org/10.1016/S0167-8140(18)32437-X

Pearson R; Pieniazek P; Thelwall P; Maxwell R; Plummer R; Frew J, 2018, 'Diffusion-weighted MRI for Early Response Assessment in the Treatment of Bladder Cancer', in CLINICAL ONCOLOGY, ELSEVIER SCIENCE LONDON, pp. 192 - 192

Jiang XY; Atkinson S; Frew J; McMenemin R; Leaning D; Pedley I, 2018, 'Radium 223 Therapy in Symptomatic Metastatic Castrate Resistant Prostate Cancer - Newcastle Experience: a Quality of Life Issue', in CLINICAL ONCOLOGY, ELSEVIER SCIENCE LONDON, pp. 194 - 194

Frew JW; Vekic DA; Woods J; Cains GD, 2017, 'A systematic review and critical evaluation of reported sequence variants in hidradenitis suppurativa/acne inversa using ACMG standards and guidelines', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY, pp. 56 - 56, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000423998100165&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Frew JW; Vekic DA; Woods J; Cains GD, 2017, 'Drug induced hidradenitis suppurativa / acne inversa: A systematic review of case reports with insights into pathogenesis of disease', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY, pp. 13 - 13, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000423998100036&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Yang X; Srinivasan S; Sullivan D; Spinks C; Frew J; Martin L, 2017, 'Intertriginous planar xanthoma secondary to dyslipidaemia in an infant', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY, pp. 104 - 104, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000423998100302&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Hao E; Frew JW; Huynh E, 2017, 'Systematic review of neonatal cutaneous langerhan cell histiocytosis and metaanlysis of risk of progression to systemic disease', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY, pp. 59 - 59, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000423998100175&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Giddings J; Frew J; Campana D; Wirtz J; Finch B, 2017, 'Concentrations of synthetic pyrethroids in surface water and sediment from agricultural and urban land use areas', in ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, AMER CHEMICAL SOC, CA, San Francisco, presented at 253rd National Meeting of the American-Chemical-Society (ACS) on Advanced Materials, Technologies, Systems, and Processes, CA, San Francisco, 02 April 2017 - 06 April 2017

Frew J; Giddings J, 2017, 'Examination of the relative contributions of aqueous and dietary uptake to pyrethroid accumulation in organisms at different aquatic trophic levels', in ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, AMER CHEMICAL SOC, CA, San Francisco, presented at 253rd National Meeting of the American-Chemical-Society (ACS) on Advanced Materials, Technologies, Systems, and Processes, CA, San Francisco, 02 April 2017 - 06 April 2017

Hendley P; Ritter A; Desmarteau D; Holmes C; Giddings J; Wirtz J; Frew J, 2017, 'Why are real-world surface water exposure distributions much lower than US EPA FIFRA Tier II EECs? An evaluation based on pyrethroid insecticides', in ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, AMER CHEMICAL SOC, CA, San Francisco, presented at 253rd National Meeting of the American-Chemical-Society (ACS) on Advanced Materials, Technologies, Systems, and Processes, CA, San Francisco, 02 April 2017 - 06 April 2017

Frew J; Wirtz J; Giddings J; Campana D, 2016, 'Analysis of monitoring data for synthetic pyrethroids in US surface water and sediment', in ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, AMER CHEMICAL SOC

Frew J; Brown J; Fitzsimmons P; Grue C; Hoffman A; Nichols J, 2016, 'Toxicokinetics of imidacloprid in rainbow trout', in ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, AMER CHEMICAL SOC

Veeratterapillay R; Gill S; Pedley I; Frew J; Heer R; Paez E; Johnson MI; Thorpe AC, 2015, 'Long-term oncological outcomes of patients undergoing neoadjuvant chemotherapy and cystectomy for muscle invasive bladder cancer', in BJU INTERNATIONAL, WILEY-BLACKWELL, ENGLAND, Manchester, pp. 75 - 75, presented at Annual Meeting of the British-Association-of-Urological-Surgeons (BAUS), ENGLAND, Manchester, 15 June 2015 - 18 June 2015, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000354476900160&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Cox VRV; Frew JW, 2015, 'Review of the proposed pathogenic mechanisms underlying rosacea and possible clinical implications of vascular and inflammatory involvement', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY-BLACKWELL, pp. 28 - 28, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000352562300078&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Leaning DJ; Jiang X; Frew J; Sarah A; Driver I; Pedley I; McMenemin R; Azzabi A, 2015, 'Outcome of Radium-223 in metastatic castrate resistant prostate cancer: an audit to assess real life experience at the Northern Centre for Cancer Care, Newcastle-upon-Tyne.', in CLINICAL ONCOLOGY, ELSEVIER SCIENCE LONDON, pp. S5 - S5, http://dx.doi.org/10.1016/j.clon.2015.04.020

Yang A; Frew JW, 2014, 'Issues surrounding topical corticosteroid use amongst dermatology patients in NSW public hospitals: A qualitative analysis and development of a topical corticosteroid patient identification chart', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY-BLACKWELL, pp. 57 - 58, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000335981400187&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Frew J; Cabrera S; Descallar J; Cains GD, 2014, 'Longitudinal analysis of psoriasis severity, metabolic syndrome and quality of life in patients on biologic therapy', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY-BLACKWELL, pp. 18 - 18, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000335981400060&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Back to profile page